Back
Biogen Vs. AbbVie Industry Stock Comparison
Sell
38
BIIB
Biogen
Last Price:
185.63
Seasonality Move:
14.8%
Sell
39
ABBV
AbbVie
Last Price:
194.26
Seasonality Move:
12.18%
Sell
38
Biogen (BIIB)
is a Sell
Is Biogen a Buy, Sell or Hold?
- The current Biogen [BIIB] share price is $185.68. The Score for BIIB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- BIIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $194.29. The Score for ABBV is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIIB Stock Price Chart
ABBV Stock Price Chart
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.34 | Sell |
| Relative Strength Index (14 RSI): | 32.05 | Sell |
| Chaikin Money Flow: | 321956 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (191.14 - 202.18) | Sell |
| Bollinger Bands (100): | (199.64 - 228.36) | Sell |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.81 | Buy |
| Relative Strength Index (14 RSI): | 50.76 | Buy |
| Chaikin Money Flow: | -191765 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (192.9 - 196.8) | Sell |
| Bollinger Bands (100): | (166.36 - 194) | Buy |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 190.15 | Sell |
| 20-day SMA: | 194.97 | Sell |
| 50-day SMA: | 200.79 | Sell |
| 200-day SMA: | 220.85 | Sell |
| 8-day EMA: | 189.82 | Sell |
| 20-day EMA: | 194.24 | Sell |
| 50-day EMA: | 201.49 | Sell |
| 200-day EMA: | 219.99 | Sell |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 194.87 | Sell |
| 20-day SMA: | 194.7 | Sell |
| 50-day SMA: | 193.13 | Buy |
| 200-day SMA: | 174.54 | Buy |
| 8-day EMA: | 195.12 | Sell |
| 20-day EMA: | 194.6 | Sell |
| 50-day EMA: | 190.81 | Buy |
| 200-day EMA: | 175.34 | Buy |
Biogen Earnings Growth & BIIB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.15 per share, and an increase next year of $0.81 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and an increase next year of $1.21 per share.
Biogen Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||